AlloSeq cfDNA
This minimally invasive transplant focused blood test in organ transplant surveillance can drive better outcomes for your patients
Donor-Derived Cell-Free DNA Testing for Organ Transplant Monitoring
Quantification of donor-derived cell-free DNA in transplant recipients. Measuring the level of donor-derived cell-free DNA may assist in improving transplant surveillance.
Cell-Free DNA (cfDNA) is fragmented DNA in the bloodstream that originates from cells undergoing cell injury and death. When graft injury occurs, donor-derived cell-free DNA (dd-cfDNA) increases in the blood. AlloSeq cfDNA measures donor-derived cell-free DNA (dd-cfDNA) utilizing low DNA input, next generation sequencing technology, and streamlined analysis to assist in improved transplant surveillance.
*AlloSeq cfDNA is available as CE/IVD or Research Use Only (RUO), depending local regulatory status. For more details on local regulatory status, please contact GenDx. RUO products are not to be used for diagnostic procedures. AlloSeq is a trademark or registered trademark of CareDx Inc. or its subsidiaries in the US or other countries and used under license. AlloSeq is a registered trademark with the US Patent and Trademark Office.